Persistent Asset Partners »

Edesa Biotech shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Edesa Biotech (EDSA) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Edesa Biotech

Tip: Access up to 7 years of quarterly data

All positions including Edesa Biotech held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edesa Biotech by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 12k 1.42

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Edesa Biotech

Rubric Capital Management
Stonepine Capital Management
Velan Capital Investment Management
Nantahala Capital Management
DRW Holdings
Diadema Partners
Geode Capital Management
Vanguard Group
State Street Corporation
Citadel Advisors
Persistent Asset Partners
Tower Research Capital
Royal Bank of Canada
UBS Group
TD Waterhouse Canada

View all funds holding Edesa Biotech